Dr. Kate Rosenbluth, PhD
Research Group Member
Dr. Kate Rosenbluth, PhD, is CEO for Cala Health. Her areas of expertise include medical devices, medical imaging, neurodegenerative disease, drug delivery, and entrepreneurship. Dr. Rosenbluth, whom completed her post-doc in Image-Guided Neurosurgery at the University of California San Francisco, is also a former fellow at the Stanford Biodesign Innovation Program and a former consultant in Biomedical Imaging for Genentech.